21 CFR 524.2350

§ 524.2350 Tolnaftate cream.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 524.2350, § 524.2350 Tolnaftate cream, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87657
Permanent ID: ys:prov:87657@1
SHA-256: 118c6810ff8a0aac6550faec13ae63bb827a3f1d2e8ac714c356586534d03441

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. The drug contains 1 percent tolnaftate in an anhydrous cream base. (b) Sponsor. See No. 000061 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount. Apply a small amount of the cream to the affected areas once or twice a day for 2 to 4 weeks. (2) Indications for use. For the treatment of ringworm lesions due to Microsporum canis and Microsporum gypseum. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.